Two New Glucagon Formulations Await FDA Approval in 2019

glucagon.jpg

If not treated quickly, mild or moderate low blood sugar can become severe. Glucagon is a treatment for very low blood sugar (severe hypoglycemia) which may affect people with diabetes. Two new versions are hoping to hit the market soon (these would be the first new types of glucagon in more than six decades).

  • After years of research, Eli Lilly has created a glucagon version that you "puff up your nose" to quickly boost blood sugar. Last summer, Lilly filed its nasal, dry powder glucagon for regulatory review in both the U.S. and Europe.

  • Xeris Pharmaceuticals has created a glucagon emergency pen that requires no mixing or prep, with an FDA meeting set for June of this year. The Xeris glucagon rescue pen would be the first ready-to-use, room-temperature stable liquid glucagon in an auto-injector to treat severe hypoglycemia.

Hopefully both will launch by the end of this year!